Vinorelbine: all 238 studies that test it

Page 3 of 3. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.

• Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate CancerCompletedNCT00151086Phase 1/2
• Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast CancerCompletedNCT00146549Phase 3
• Study of Gemcitabine and Vinorelbine in Soft Tissue SarcomasCompletedNCT00134641Phase 2
• Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast CancerCompletedNCT00103233Phase 3
• Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00079287Phase 3
• Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's LymphomaCompletedNCT00070304Phase 2
• Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerTerminatedNCT00054197Phase 3
• Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast CancerTerminatedNCT00049660Phase 2/3
• A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00042315Phase 3
• S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00026156Phase 2
• Vinorelbine in Treating Older Women With Stage IV Breast CancerCompletedNCT00022152Phase 2
• Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00017459Phase 3
• Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast CancerCompletedNCT00017394Phase 2
• S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast CancerCompletedNCT00015938Phase 2
• Chemotherapy Plus Trastuzumab in Treating Patients With Breast CancerCompletedNCT00014430Phase 1
• Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00008333Phase 2
• Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's LymphomaCompletedNCT00006760Phase 2
• Vinorelbine and Docetaxel in Treating Women With Metastatic Breast CancerCompletedNCT00006682Phase 2
• Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00006215Phase 2
• Vinorelbine in Treating Patients With Metastatic or Advanced Solid TumorsStatus unknownNCT00006088Phase 1
• Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's LymphomaCompletedNCT00006029Phase 1/2
• Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00005865Phase 2
• Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerStatus unknownNCT00004100Phase 3
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung CancerTerminatedNCT00004093Phase 1/2
• Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell TransplantationCompletedNCT00003963Phase 2
• Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone InvolvementCompletedNCT00003902Phase 1/2
• S9804: Vinorelbine in Treating Patients With Stage IV MelanomaCompletedNCT00003828Phase 2
• Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast CancerCompletedNCT00003730Not applicable
• Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone TherapyWithdrawnNCT00003622Phase 2
• S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00003587Phase 2
• Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney CancerCompletedNCT00003584Phase 2
• Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerStatus unknownNCT00003447Phase 3
• Vinorelbine in Treating Patients With Metastatic Prostate CancerCompletedNCT00003259Phase 2
• Vinorelbine in Treating Children With Recurrent or Refractory CancersCompletedNCT00003234Phase 2
• Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the PelvisCompletedNCT00002949Phase 1
• Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical CancerCompletedNCT00002813Phase 2
• Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically RemovedCompletedNCT00002583Phase 3
• Vinorelbine and XR9576 to Treat CancerCompletedNCT00001944Phase 1

← Vinorelbine overview